Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
American Journal of Ophthalmology
|
September 6, 2005
Late reopening and spontaneous closure of previously repaired macular holes
Jeffrey G Gross
JAMA Ophthalmology
|
November 20, 2015
A Novel Treatment for Proliferative Diabetic Retinopathy: Anti-Vascular Endothelial Growth Factor Therapy
Jeffrey G Gross, Adam R Glassman
JAMA Ophthalmology
|
April 22, 2016
Panretinal Photocoagulation vs Anti-Vascular Endothelial Growth Factor for Proliferative Diabetic Retinopathy-Reply
Jeffrey G Gross, Adam R Glassman
American Journal of Ophthalmology
|
April 3, 2004
In-the-bag intraocular lens dislocation
Jeffrey G Gross, Gregg T Kokame, David V Weinberg, et al.
American Journal of Ophthalmology
|
March 16, 2017
Reply
Wesley T Beaulieu, Neil M Bressler, Jeffrey G Gross, et al.
Retina (Philadelphia, Pa.)
|
January 20, 2022
Diagnostic and Therapeutic Challenges
Wen-Yan Peng, Shi-You Zhou, Jin Ma, et al.
Retina (Philadelphia, Pa.)
|
October 6, 2005
Diagnostic and therapeutic challenges
Lucy H Y Young, Jeffrey G Gross, James C Lai, et al.
JAMA Ophthalmology
|
May 12, 2017
Interim Safety Data Comparing Ranibizumab With Panretinal Photocoagulation Among Participants With Proliferative Diabetic Retinopathy
Jeffrey G Gross, Adam R Glassman, Margaret J Klein, et al.
Ophthalmic Surgery, Lasers & Imaging Retina
|
September 18, 2018
Visual Acuity Outcomes in Diabetic Macular Edema With Fluocinolone Acetonide 0.2 μg/Day Versus Ranibizumab Plus Deferred Laser (DRCR Protocol I)
Michael A Singer, Dan M Miller, Jeffrey G Gross, et al.
Ophthalmology
|
July 8, 2018
Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Factors Associated with Vision and Edema Outcomes
Susan B Bressler, Wesley T Beaulieu, Adam R Glassman, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
American Journal of Ophthalmology
|
September 6, 2005
Late reopening and spontaneous closure of previously repaired macular holes
Jeffrey G Gross
JAMA Ophthalmology
|
November 20, 2015
A Novel Treatment for Proliferative Diabetic Retinopathy: Anti-Vascular Endothelial Growth Factor Therapy
Jeffrey G Gross, Adam R Glassman
JAMA Ophthalmology
|
April 22, 2016
Panretinal Photocoagulation vs Anti-Vascular Endothelial Growth Factor for Proliferative Diabetic Retinopathy-Reply
Jeffrey G Gross, Adam R Glassman
American Journal of Ophthalmology
|
April 3, 2004
In-the-bag intraocular lens dislocation
Jeffrey G Gross, Gregg T Kokame, David V Weinberg, et al.
American Journal of Ophthalmology
|
March 16, 2017
Reply
Wesley T Beaulieu, Neil M Bressler, Jeffrey G Gross, et al.
Retina (Philadelphia, Pa.)
|
January 20, 2022
Diagnostic and Therapeutic Challenges
Wen-Yan Peng, Shi-You Zhou, Jin Ma, et al.
Retina (Philadelphia, Pa.)
|
October 6, 2005
Diagnostic and therapeutic challenges
Lucy H Y Young, Jeffrey G Gross, James C Lai, et al.
JAMA Ophthalmology
|
May 12, 2017
Interim Safety Data Comparing Ranibizumab With Panretinal Photocoagulation Among Participants With Proliferative Diabetic Retinopathy
Jeffrey G Gross, Adam R Glassman, Margaret J Klein, et al.
Ophthalmic Surgery, Lasers & Imaging Retina
|
September 18, 2018
Visual Acuity Outcomes in Diabetic Macular Edema With Fluocinolone Acetonide 0.2 μg/Day Versus Ranibizumab Plus Deferred Laser (DRCR Protocol I)
Michael A Singer, Dan M Miller, Jeffrey G Gross, et al.
Ophthalmology
|
July 8, 2018
Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Factors Associated with Vision and Edema Outcomes
Susan B Bressler, Wesley T Beaulieu, Adam R Glassman, et al.
Page
of 3